trending Market Intelligence /marketintelligence/en/news-insights/trending/ixiygwetbxvbkidggqx_ug2 content esgSubNav
In This List

Acceleron Pharma appoints chief medical officer

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Acceleron Pharma appoints chief medical officer

Acceleron Pharma Inc. said July 5 that Robert Zeldin was appointed chief medical officer.

The Cambridge, Mass.-based biopharmaceutical company said Zeldin recently served as chief medical officer of Belgium-based Ablynx NV, now a unit of Sanofi.

Previously, Zeldin served as vice president and U.S. medical franchise head of respiratory and dermatology at Novartis AG's Novartis Pharmaceuticals and senior vice president and head of global clinical development at Stallergenes SA.